Merck’s subsidiary wins $2.5bn patent verdict against Gilead Sciences
A jury in the US District Court for the District of Delaware ordered Gilead Sciences to pay $2.54bn in damages to Merck's subsidiary Idenix Pharmaceuticals for infringing its patents in…
Read More...
Read More...